Edgemont Partners

We see sustained strong appetite for life science regulatory services globally given the significant incremental value and cost savings that life science sponsors can realize through expediting the regulatory approval process. This category of outsourced life science services remains one of the least outsourced areas today, albeit with one of the fastest projected growth rates and with substantial runway to grow. Moreover, this expertise carries highly strategic value for services providers, as it can serve as the tip-of-the-spear offering, driving early, meaningful, and regular engagement with life science clients, as well as high-impact, high-margin, high-predictability, reoccurring, and entrenched relationships with sponsor clients. Read more about our key perspectives on the market dynamics, growth drivers, and valuation considerations, including recent precedent M&A transactions: https://hubs.li/Q02LGrgY0

Edgemont Managing Director, Eugene Goldenberg, recently spoke with Hospice News about private equity in the hospice merger and acquisition landscape. Read his insights here: https://hubs.li/Q02XPLYt0

Edgemont congratulates Collaborating Docs on its recapitalization by TT Capital Partners. Edgemont is pleased to have advised Collaborating Docs on this transaction. For additional information, please see our website here: https://hubs.li/Q02X08Nj0 Read the press release: https://hubs.li/Q02W_V5v0

Edgemont Managing Director, Eugene Goldenberg, recently spoke on a panel at the McGuireWoods' 17th Annual Healthcare Finance and Growth Conference. Read more about his takeaways from the discussion here: https://hubs.li/Q02V_9-t0

The #DrivingtheDeal podcast is back with a new #BankersCorner episode! Brian Fortune is joined by Eugene Goldenberg, Managing Director at Edgemont Partners. Together, they explore the dynamic post-acute care sector and offer a deep dive into the current state of the market, highlighting key trends in personal care, hospice, and home health, uncovering the challenges and opportunities investors face in this space and the broader healthcare M&A landscape. Eugene also shares his insights and predictions for the future of post-acute care. Stay up to date with current episodes by following McDermott Will & Emery and Farragut Square Group! Spotify: https://lnkd.in/ekqj8Rtj Amazon: https://lnkd.in/eZd_yDXB #healthcare #privateequity #podcast #MergersandAcquisitions #dealmarket

Edgemont congratulates PHAR (Partnership for Health Analytic Research) on its sale to ADVI Health, backed by Sheridan Capital Partners. Edgemont is pleased to have advised PHAR on this transaction. For additional information, please see our website here: https://hubs.ly/Q02Mwf-X0 Read the press release: https://hubs.ly/Q02Mwkwr0

Edgemont Managing Directors, Andrew R. Karlin and Sam Fertitta, were recently quoted in PitchBook's inaugural industry primer on the pharmaceutical services sector. Read the full report below. https://hubs.li/Q02K2tb70

The global CDMO market is estimated to be an $80 billion industry, experiencing an 11%+ CAGR. The United States leads as the largest market, valued at $23 billion, and is anticipated to sustain double-digit growth over the next five years. This growth is propelled by several factors, including the rise in robotic and minimally invasive surgeries, a shift towards local sourcing, and the consolidation of OEM suppliers. M&A remains robust in both activity and valuation, highlighted by the formation of over 15 private equity-backed medtech platforms since 2020. These platforms are actively pursuing a roll-up strategy, acquiring small CDMOs to augment their growth trajectory and expand their capabilities. Read more about our key perspectives on the market dynamics, growth drivers, and valuation considerations, including recent precedent M&A transactions: https://hubs.ly/Q02Bmy3F0

Edgemont congratulates Zenyth Partners on its recapitalization of LifeCare Home Health Family. Edgemont is pleased to have advised Zenyth Partners on this transaction. For additional information, please see our website here: https://hubs.li/Q02B5bF50 Read the press release: https://hubs.li/Q02B58Q_0

Edgemont congratulates BW Health Group on its acquisition by Danforth Advisors, a portfolio company of Avesi Partners. Edgemont is pleased to have advised BW Health Group on this transaction. For additional information, please see our website here: https://hubs.li/Q02z3HNT0